Dec 2023 – Aug 2025 · 1 yr 8 mos · Gurugram, Haryana, India

Jul 2021 – Nov 2023 · 2 yrs 4 mos · Pune, Maharashtra, India

• Developed statistical forecasting models rooted in epidemiology for a diverse range of pharmaceutical
• assets, covering early and late-stage development, while meticulously analyzing financial performance and demand trends across a multitude of markets, including G7 countries and specific regional markets.
• Possess in-depth expertise in therapy areas such as Immunology and Oncology, enabling a comprehensive understanding of the intricacies of these domains.
• Supported Commercial teams in long term forecast, demand planning, revenue submissions, investor presentations, forecast cycles for an inline product in RA market
• Conducted extensive secondary research to verify epidemiological data and created a Competitive landscape using ct.gov for the pipeline products in the IPF market, ensuring the utmost accuracy and reliability.
• Worked on a Multiple Myeloma model during a pay-for-delay scenario involving Paragraph IV litigation from competitor companies. Developed a forecasting tool to estimate TRx for these competitors, accounting for their limited dispensing rights over specific time periods.
• Held responsibility for the preparation of quarterly Investor Relations reports, executed ad hoc reporting activities, and gleaned valuable insights from competitors' earnings calls, particularly for relevant brands.